ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors.

https://repo.qst.go.jp/records/45854
https://repo.qst.go.jp/records/45854
9b575c75-32ec-444d-971a-7a7429dc87a0
Item type 学術雑誌論文 / Journal Article(1)
公開日 2010-07-12
タイトル
タイトル Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors.
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Hirose, Hajime

× Hirose, Hajime

WEKO 456049

Hirose, Hajime

Search repository
Ishii, Hideshi

× Ishii, Hideshi

WEKO 456050

Ishii, Hideshi

Search repository
Mimori, Koshi

× Mimori, Koshi

WEKO 456051

Mimori, Koshi

Search repository
Saito, Toshiyuki

× Saito, Toshiyuki

WEKO 456052

Saito, Toshiyuki

Search repository
Sekimoto, Mitsugu

× Sekimoto, Mitsugu

WEKO 456053

Sekimoto, Mitsugu

Search repository
Doki, Yuichiro

× Doki, Yuichiro

WEKO 456054

Doki, Yuichiro

Search repository
Mori, Masaki

× Mori, Masaki

WEKO 456055

Mori, Masaki

Search repository
et.al

× et.al

WEKO 456056

et.al

Search repository
石井 秀始

× 石井 秀始

WEKO 456057

en 石井 秀始

Search repository
齋藤 俊行

× 齋藤 俊行

WEKO 456058

en 齋藤 俊行

Search repository
抄録
内容記述タイプ Abstract
内容記述 Whereas the Her2/neu/erbB2 receptor (Her2) could be a molecular target of the receptor-positive breast cancer, the therapeutic targets of Her2-negative cancer largely remain to be established. The expression of Her2 was evaluated in 48 primary breast cancer tumors by immunohistochemistry. The identified Notch pathway was studied in genotoxin-dependent suppression of breast cancer-initiating cell growth. Immunohistochemical assessment of Her2-negative tumors revealed significant association with overexpression of Notch1 and Notch3. Knockdown of Notch pathway resulted in sensitization of breast cancer cells to deionizing radiation, leading to cell death; the effect was more significant in stem marker CD44+ than in CD44- cells, and more profound in the Her2-negative than in positive cancer cells. The present study indicates that inhibition of Notch signaling could antagonize survival signal of Her2-negative breast cancer-initiating cells carrying genomic damage, and suggests that targeted suppression of the Notch pathway may give the rationale for sensitizing Her2-negative cancer-initiating cells to a therapeutic approach.
書誌情報 Oncology Reports

巻 23, 号 1, p. 35-43, 発行日 2010-01
ISSN
収録物識別子タイプ ISSN
収録物識別子 1021-335X
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 23:58:49.705622
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3